Nucala

UNIISPLATC R03DX09

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerGlaxoSmithKline LLC

CountryUS (United States)

ATC codeR03DX09

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 2

ndc11
0173088101
1 VIAL in 1 CARTON (0173-0881-01) / 1 mL in 1 VIAL
ndc11
0173088161
1 VIAL in 1 CARTON (0173-0881-61) / 1 mL in 1 VIAL

Annotations

UNII (FDA Substance ID)

90Z2UF0E52

MEPOLIZUMAB

RxCUI 1720597

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "90Z2UF0E52",
    "rxcui": "1720597",
    "inchikey": null,
    "display_name": "MEPOLIZUMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "SUBCUTANEOUS",
  "spl_meta": {
    "fefb887c-e4ac-431e-8893-e9d1a5a63fea": {
      "match": "brand_token",
      "title": "NUCALA (MEPOLIZUMAB) INJECTION, POWDER, FOR SOLUTION NUCALA (MEPOLIZUMAB) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC]",
      "spl_version": "24",
      "published_date": "2025-08-18"
    }
  },
  "productid": "0173-0881_869b75ba-b2a0-406e-9ed2-136b75763d78",
  "productndc": "0173-0881",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "MEPOLIZUMAB",
  "proprietary_name": "Nucala",
  "active_ingred_unit": "mg/mL",
  "application_number": "BLA125526",
  "marketing_category": "BLA",
  "nonproprietary_name": "mepolizumab",
  "start_marketing_date": "20151104",
  "active_numerator_strength": "100"
}

Related drugs

Other records sharing ATC code R03DX09.

Access this data programmatically

Query Nucala and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs